EB-1A Approval for a Medical Researcher in Regenerative Medicine

On Januart 26, 2026, we successfully secured another EB-1A approval for a Medical Researcher (PhD) specializing in Regenerative Medicine without RFE.

General Field

Regenerative Medicine

Background

23 published papers (5 First Author)

838 citation

Case Details

Case Filed: January 5, 2026

Case Approved: January 26, 2026

Processed at: USCIS Texas Service Center

Case Summary

The applicant holds a PhD’s degree in Surgery, specializing in regenerative medicine. By combining stem cells with engineered materials, his pioneering methodologies accelerate healing while reducing complications and offer promising solutions for countless patients worldwide suffering from degenerative diseases and chronic issue conditions. Following his previous NIW approval, we highlighted the practical implications of his research, which ultimately led to his successful EB-1A approval.